STAAR Surgical Co (STAA): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand STAAR Surgical Corp (STAA)

STAAR Surgical Company (STAA) maintains strong pricing power based on the uniqueness of EVO lenses, as evidenced by the price-to-sales ratio, which currently stands at 4.00. Robotic manufacturing integrated with machine vision minimizes defects, although development requires specialized experts. The aggressive expansion of implantable products is currently displacing laser vision correction and capturing the global market.

Price-to-Revenue Ratio: STAAR Surgical (STAA) for 07/04/2022 - 11/15/2026

Metric breakdowns and analytics for STAAR Surgical (STAA)

- stock quotes and analyst forecast:
Price STAAR Surgical Co.|STAA - Price Target Chart
- stock exchange capitalization data:
Market Value STAAR Surgical Company|STAA - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share STAAR Surgical|STAA - Company Book Value|Market Cap to Net Assets Ratio staar.com|STAA - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital STAAR Surgical Company|STAA - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio STAAR Surgical|STAA - Company Total Debt|Debt to Book Capital STAAR Surgical|STAA - Company Long-Term Debt|Short-Term Debt Volume STAAR Surgical|Interim Coverage Ratio staar.com
- company profitability and valuation multiples indicators:
STAA - Net Income|Future Net Profit STAAR Surgical Company|STAA - P/E Multiple|Forward P/E Multiple STAAR Surgical Corp|STAA - PEG Multiple|EV/EBITDA Multiple STAAR Surgical|STAA - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year STAAR Surgical|STAA - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months staar.com|STAA - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year STAAR Surgical Company
- total revenue and sales volume data:
STAA - Company Sales|Projected Sales Volume STAAR Surgical Co.|STAA - Price-to-Revenue Ratio|Forward Price to Sales STAAR Surgical Co
Summary company analytics:STAAR Surgical Co.
Mass-produced product of staar.com

The high-margin business of STAAR Surgical (STAA) producing implantable lenses with sustainable demand is reflected in the P/S time series. This metric, calculated as the ratio of market capitalization to annual sales volume, determines the cost of each unit of revenue, allowing investors to assess the market premium for the issuer's stable profit generation and technological leadership.

Competitors of STAAR Surgical Company

Market Cap to Sales Volume ISRG|Danaher Corporation - Market Cap to Revenue|P/S Multiple Becton Dickinson & Company BDX|STE - Price-to-Revenue Ratio|West Pharmaceutical Services (WST) - Market Cap to Revenue|BAX: P/S Multiple|Market Cap to Revenue Masimo|STVN (stevanatogroup.com) - P/S Multiple|Market Cap to Revenue Ratio TFX (Teleflex Incorporated)|Price-to-Revenue Ratio Merit Medical (MMSI)|Envista - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (Dentsply Sirona Inc)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Corp ATRC|NAGE: P/S Multiple|Price-to-Sales Ratio ZIMV (ZimVie Inc.)|Price-to-Revenue Ratio AngioDynamics Corp|Price to Sales Cerus Corp. CERS|Price-to-Revenue Ratio Teknova (TKNO)|Monogram Orthopedics Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio Sharps Technology, Inc. STSS|P/S Multiple InfuSystem Holdings INFU|UTMD: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio KRMD (KORU Medical)|NYXH: P/S Multiple|MBOT (Microbot Medical, Inc) - Price-to-Revenue Ratio|Market Cap to Revenue PDEX|ZTEK: Market Capitalization-to-Revenue Ratio|P/S Multiple ELUT|Milestone Scientific Inc. - Market Cap to Revenue Ratio|Price-to-Revenue Ratio NEXGEL, Inc. NXGL|Retractable Tech - Price-to-Revenue Ratio|harvardbioscience.com - P/S Multiple|FEMY (Femasys Inc.) - Market Cap to Revenue Ratio|MHUA: P/S Multiple|Predictive Oncology Corp - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB) - P/S Multiple|Price to Sales Atrion Corporation Inc. ATRI|P/S Multiple NURO